SMTL ID : 5qqp.1

FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.08 Å

Oligo State

monomer

Ligands

1 x NR7: methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate(Non-covalent)

NR7.1: 24 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, C.45, Y.134, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.28, A:I.141, A:A.183, A:T.206 Hydrogen bonds: A:R.26, A:H.27, A:L.28, A:G.186, A:D.187, A:S.188 Water bridges: A:R.26, A:R.26, A:K.185, A:K.185

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: R.161, R.177 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.161, A:R.177

8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 5 residues within 4Å: Chain A: N.36, T.102, V.103, G.104, Y.105 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.36, A:Y.105 Water bridges: A:Y.105 EDO.4: 9 residues within 4Å: Chain A: V.8, R.9, G.10, E.11, W.12, P.13, I.61, L.62, L.145 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.10, A:G.10, A:W.12, A:I.61 EDO.5: 6 residues within 4Å: Chain A: S.90, G.91, Y.92, T.168, K.170, M.171 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.90, A:Y.92, A:T.168 EDO.6: 9 residues within 4Å: Chain A: V.153, E.157, R.161, G.175, Y.176, R.177, E.216, R.217, P.218 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:E.157, A:E.157, A:R.161, A:Y.176 Water bridges: A:R.217 EDO.7: 5 residues within 4Å: Chain A: N.155, H.169, M.171, I.172, N.223 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:H.169, A:N.223 Water bridges: A:V.153, A:N.155, A:N.155 EDO.8: 4 residues within 4Å: Chain A: E.11, W.12, W.128, K.147 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.147 Water bridges: A:W.200 EDO.9: 2 residues within 4Å: Chain A: T.168, H.169 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.169 Water bridges: A:K.170 EDO.10: 1 residues within 4Å: Chain A: R.9 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.9 Water bridges: A:R.9, A:N.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Clark, C.G. et al., Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability. Bioorg.Med.Chem.Lett. (2019)

Release Date

2019-09-18

Peptides

Coagulation factor XI: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Coagulation factor XI

Related Entries With Identical Sequence